Technology
The world’s first portable platform for cell measurement
The world’s first portable platform for cell measurement
Our proprietary Aster™ platform uses lateral flow technology to enable the measurement of both cell-based and soluble biomarkers from a single sample, in a rapid, easy-to-use and portable format. The technology is protected by patents and know-how, with numerous potential applications in emergency care.
Patented mechanism separates cells and solutes to allow dual analysis in lateral flow
Patented microfluidic system automates sample processing
Remotely monitor patients anywhere, anytime
We work with strategic partners to co-develop and commercialise high-value opportunities under the Aster™ platform.
In December 2024, 52North was selected from over 2,600 candidates to be part of the inaugural ‘human health and performance’ vertical on the prestigious NATO DIANA accelerator programme. The programme saw 52North build, validate, and test a dual-use business case for the Aster™ technology. We have developed a new product, ARC™, to strengthen the medical resilience capability of the NATO Alliance. It enables remote triaging and treatment monitoring of individuals at risk of radiation sickness, ensuring those in need receive quick access to life-saving drugs.
By enabling the rapid and remote measurement of cells, Aster™ can be used by pharmaceutical companies to support drug development, drug safety and drug targeting. For example, Neutrocheck® can be used to enable at-home treatment monitoring in clinical trials.
52North is working with one of the world’s leading diagnostic companies to co-develop a new product that can remotely measure platelets using the Aster™ platform.